A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
2021 ◽
2013 ◽
Vol 8
(6)
◽
pp. 491-504
◽
1998 ◽
Vol 273
(40)
◽
pp. 26001-26007
◽
Keyword(s):
2011 ◽
Vol 42
(3)
◽
pp. 360-367
◽
2015 ◽
Vol 36
(2)
◽
pp. 1209-1220
◽
2011 ◽
Vol 69
(5 Part 1)
◽
pp. 390-394
◽
Keyword(s):
2002 ◽
Vol 43
(47)
◽
pp. 8621-8623
◽
2009 ◽
Vol 1
(1)
◽
pp. 71-75
◽